NCT02853630View on ClinicalTrials.gov

A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

November 30, 2017

Study Completion Date

December 31, 2018

Conditions
TYpe 2 Diabetes Mellitus
Interventions
DRUG

Metformin

Participant will be instructed to take Metformin tablets as per instructions given by the physician.

DRUG

Vildagliptin

Participant will be instructed to take one tablet of Vildagliptin 50mg per day, 30 minutes after breakfast in the morning and second tablet at night, 30 minutes after dinner

Trial Locations (6)

600029

Dr V.Seshiah Diabetes research Institute, Dr V.Balaji Diabetes care centre, Chennai

560 078

Jnana Sanjeevini Medical Centre, Bangalore

411 005

Vikas Pai Research Foundation, Pune

600 019

Singhvi Health Centre, Chennai

625 020

Arthur Asirvatham Hospital, Madurai

606 603

Ramana Maharishi Rangammal Hospital, Tiruvannamalai

All Listed Sponsors
lead

India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals

OTHER

NCT02853630 - A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter